603 A randomized, placebo-controlled, first in human phase I single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy male volunteers of the immunostimulant 7HP349

Lionel Lewis, William Schary, Siddhartha De, Peter Vanderslice, Ronald Biediger, Yared Hailemichael, Darren Woodside, William Overwijk, Frank Lee, Upendra Marathi
2022 Regular and Young Investigator Award Abstracts   unpublished
doi:10.1136/jitc-2022-sitc2022.0603 fatcat:4nf3npr5vncyhodghbuwz34u7u